Skip to main content
Equibles

Dan Lyons

Verastem, Inc. (VSTM)

Equibles does not estimate personal net worth.

Get an email with a short summary when Verastem, Inc. publishes a filing, an earnings call transcript or a press release.

Get VSTM alerts

About Dan Lyons

Dan Lyons has spoken on 1 earnings call and 1 other investor event across 1 company, most recently for Verastem, Inc. on August 6, 2026. Verastem, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Verastem, Inc. includes Brian M. Stuglik (CEO), Daniel Paterson (CEO and Board Member), Michael Bailey (CEO) and 7 others.

Dan Lyons on recent calls

“We continue to make meaningful progress in the second quarter as the launch matures. We are pleased with the quarterly sales of a map defect into Copac, $25.1 million.”
Other, Verastem Oncology 2Q26 Earnings Call ·
“I joined Veristem Oncology just over a month ago. Prior to this, I was at SpringWorks Therapeutics, and as coming in, the opportunity I saw specifically with Copac to serve these patients in a rare oncology with a targeted treatment was very exciting.”
Other, Jefferies Global Healthcare Conference ·

Affiliation history

Company network

Leadership on record at Verastem, Inc.

Recent activity